Transaction DateRecipientSharesTypePriceValue
19th January 2021John F Sullivan9,617Open or private sale$22.12$212,728.04
19th January 2021John F Sullivan9,617Exercise of derivative$0.39$3,750.63
4th January 2021Stephen Gordon1,184Open or private sale$20.00$23,680.00
31st December 2020Stephen Gordon8,816Open or private sale$20.00$176,320.00
21st December 2020John F Sullivan1,000Open or private sale$17.99$17,990.00
16th December 2020John F Sullivan1,000Exercise of derivative$0.39$390.00
15th December 2020John F Sullivan3,000Exercise of derivative$0.39$1,170.00
15th December 2020John F Sullivan3,000Open or private sale$16.63$49,890.00
11th December 2020Miriam Provost4,600Exercise of derivative$3.22$14,812.00
23rd November 2020Ventures Fund Iv General Partner Llc Flagship3,587,820Other acquisition or disposition$0.00
Trans Medics Group
Trans Medics Group logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


TransMedics Group, Inc. focuses on the preservation of human organs for transplant in a near-physiologic condition. The company was founded by Waleed H. Hassanein in October 2018.


Ticker: TMDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1756262
Employees: 109
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals